Patent Yard Sign in
Canadian application, no grantCanada

Methods for the treatment of carcinoma

CA 2463492 A1 · Owner: Peale, Franklin V. Jr. · Inventors: Wu, Thomas D.; Gerritsen, Mary E.; Peale, Franklin V. Jr.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals including , humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells such as renal cell carcinoma. Such , gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly the proteins encoded by the , amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers such as renal cell , carcinoma, and may act as …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 16, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 16, 2002
GrantedNo grant recorded
Term endedOctober 16, 2022
Patent numberCA 2463492 A1
Classification (IPC)C07K16/00 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedOct 16, 2002Term endedOct 16, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.